Marlio Charles Mosseri - 07 Feb 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
10%+ Owner
Signature
/s/ Charles Mosseri-Marlio
Issuer symbol
NVCT
Transactions as of
07 Feb 2025
Net transactions value
+$1,200,000
Form type
4
Filing time
11 Feb 2025, 17:58:35 UTC
Previous filing
16 Dec 2024
Next filing
12 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1,200,000 +240,000 +9.1% $5.00 2,884,121 07 Feb 2025 By Emerald Hill Ventures SARL SPF. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.